Literature DB >> 6611348

12-O-Tetradecanoylphorbol-13-acetate (TPA) directly inhibits spontaneous immunoglobulin secretion by in vivo antigen-induced human lymphoblastoid B cells.

J A Brieva, J S Louie, R H Stevens.   

Abstract

Tetanus toxoid (Tet) booster immunization induces the transient appearance in the circulation of lymphoblastoid (LB) B cells which spontaneously produce anti-tetanus toxoid IgG antibody (IgG-Tet) during a 3-day in vitro culture. In this study we have examined the effects of TPA on the ability of LB cells to secrete antibody and have found that as little as 10 ng/ml of TPA provoked a marked inhibition of the induced LB cells' IgG-Tet production. This inhibitory effect was observed only when TPA was added early in the culture and could be achieved by pretreating the B cells with TPA for as little as 1 hr. Only marginal inhibition of IgG-Tet production was observed if the addition of TPA was delayed 14-24 hr. The TPA inhibition was not mediated by contaminant T cells as the addition of increasing numbers of T cells to LB cell cultures proportionally reversed the TPA inhibitory effect. Likewise, the inhibition of antibody synthesis was not due to a monocyte-dependent mechanism since (1) substantial depletion of adherent cells did not reverse the inhibition of antibody synthesis, (2) the addition of a monocyte-enriched population to monocyte-depleted B cells did not enhance, but in fact partially reversed, the inhibition caused by TPA, and (3) the addition of monocyte populations pretreated with TPA to monocyte-depleted B-cell fractions did not inhibit subsequent IgG-Tet production by the LB cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611348     DOI: 10.1007/bf00915295

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  36 in total

Review 1.  Tumor-promoting agents in two-stage carcinogenesis.

Authors:  B L Van Duuren
Journal:  Prog Exp Tumor Res       Date:  1969

2.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

3.  Isolation and enumeration of peripheral blood monocytes.

Authors:  R J Sanderson; R T Shepperdson; A E Vatter; D W Talmage
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

4.  Inhibition of human antigen-induced lymphoblastoid B-cell function by an in vivo-induced suppressor T cell.

Authors:  J A Brieva; R H Stevens
Journal:  Cell Immunol       Date:  1983-04-01       Impact factor: 4.868

5.  Clues to cell growth and differentiation.

Authors:  G Kolata
Journal:  Science       Date:  1983-04-15       Impact factor: 47.728

6.  Multiple subsets of anti-tetanus toxoid antibody-producing cells in human peripheral blood differ by size, expression of membrane receptors, and mitogen reactivity.

Authors:  C J Thiele; C D Morrow; R H Stevens
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Relationship of cell cycle to recovery of IL 2 activity from human mononuclear cells, human and mouse T cell lines.

Authors:  B M Stadler; S F Dougherty; J J Farrar; J J Oppenheim
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

8.  Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines.

Authors:  P Ralph; T Kishimoto
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.

Authors:  W W Ginsburg; F D Finkelman; P E Lipsky
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

10.  Modulation of human T-cell differentiation markers by 12-O-tetradecanoylphorbol-13-acetate.

Authors:  K Nagasawa; B E Chechik; E W Gelfand; S Sengupta; M Letarte; T W Mak
Journal:  Thymus       Date:  1981-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.